Clinical Trial Update: A Study of AP402 in HER2-Positive Patients With Locally or Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update announcing a Phase 1/2 study of AP402 in HER2-positive locally advanced or advanced solid tumors; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• AP402

Snippet

Sponsor: AP Biosciences Inc. | Conditions: Advanced Solid Tumor | Phase 1, Phase 2 | Status: RECRUITING